The DOI matches its Crossref record; 411 of the 411 references it cites were found in a registry or an index.
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
Open accessAbstract
T cells play a critical role in cancer control, but a range of potent immunosuppressive mechanisms can be upregulated in the tumor microenvironment (TME) to abrogate their activity. While various immunotherapies (IMTs) aiming at re-invigorating the T-cell-mediated anti-tumor response, such as immune checkpoint blockade (ICB), and the adoptive cell transfer (ACT) of natural or gene-engineered ex vivo expanded tumor-specific T cells, have led to unprecedented clinical responses, only a small proportion of cancer patients benefit from these treatments. Important research efforts are thus underway to identify biomarkers of response, as well as to develop personalized combinatorial approaches that can target other inhibitory mechanisms at play in the TME. In recent years, adenosinergic signaling has emerged as a powerful immuno-metabolic checkpoint in tumors. Like several other barriers in the TME, such as the PD-1/PDL-1 axis, CTLA-4, and indoleamine 2,3-dioxygenase (IDO-1), adenosine plays important physiologic roles, but has been co-opted by tumors to promote their growth and impair immunity. Several agents counteracting the adenosine axis have been developed, and pre-clinical studies have demonstrated important anti-tumor activity, alone and in combination with other IMTs including ICB and ACT. Here we review the regulation of adenosine levels and mechanisms by which it promotes tumor growth and broadly suppresses protective immunity, with extra focus on the attenuation of T cell function. Finally, we present an overview of promising pre-clinical and clinical approaches being explored for blocking the adenosine axis for enhanced control of solid tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 411
Detecting adenosine triphosphate in the pericellular space
Falzoni, S., Donvito, G., & Di Virgilio, F. (2013) · Interface Focus · doi:10.1098/rsfs.2012.0101 · Cited by 136
Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., MacLennan, S., & Borea, P. A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.020 · Cited by 133
Narravula, S., Lennon, P., Mueller, B. U., & Colgan, S. P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5262 · Cited by 133
Kjaergaard, J., Hatfield, S., Jones, G., Ohta, A., & Sitkovsky, M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700850 · Cited by 132
Zhang, H., Conrad, D., Butler, J. J., Zhao, C., Blay, J., & Hoskin, D. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.932 · Cited by 130
Khoa, N. D., Montesinos, M. C., Williams, A. J., Kelly, M., & Cronstein, B. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.3991 · Cited by 130
Sheridan, C. M., Heist, E. K., Beals, C. R., Crabtree, G. R., & Gardner, P. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207029200 · Cited by 130
Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model.
Iannone, R., Miele, L., Maiolino, P., Pinto, A., & Morello, S. (2014) · Europe PMC (PubMed Central) · Cited by 129
Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
Alvarez, R., Sette, C., Yang, D., Eglen, R. M., Wilhelm, R. S., Shelton, E. R., & Conti, M. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10513-0 · Cited by 129
Fredholm, B. B., Zhang, Y., & van der Ploeg, I. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00171056 · Cited by 129
Ramanathan, M., Pinhal‐Enfield, G., Hao, I., & Leibovich, S. J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-07-0596 · Cited by 129
Expression of A2B adenosine receptors in human lymphocytes: Their role in T cell activation
Mirabet, M., Herrera, C., Cordero, O. J., Mallol, J., Lluís, C., & Franco, R. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.4.491 · Cited by 128
Poth, J. M., Brodsky, K. S., Ehrentraut, H., Grenz, A., & Eltzschig, H. K. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0988-7 · Cited by 127
Role of TGF-β Signaling in Generation of CD39+CD73+ Myeloid Cells in Tumors
Ryzhov, S. V., Pickup, M. W., Chytil, A., Gorska, A. E., Zhang, Q., Owens, P., Feoktistov, I., Moses, H. L., & Novitskiy, S. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400578 · Cited by 126
Adenosine Deamination Sustains Dendritic Cell Activation in Inflammation
Desrosiers, M. D., Cembrola, K., Fakir, M. J., Stephens, L. A., Jama, F. M., Shameli, A., Mehal, W. Z., Santamaría, P., & Shi, Y. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1884 · Cited by 125
Malesci, A., Bianchi, P., Celesti, G., Basso, G., Marchesi, F., Grizzi, F., Di Caro, G., Cavalleri, T., Rimassa, L., Palmqvist, R., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1342918 · Cited by 124
Volmer, J. B., Thompson, L. F., & Blackburn, M. R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4449 · Cited by 124
Adenosine regulates CD8 T‐cell priming by inhibition of membrane‐proximal T‐cell receptor signalling
Linnemann, C., Schildberg, F. A., Schurich, A., Diehl, L., Hegenbarth, S. I., Endl, E., Lacher, S. K., Müller, C. E., Frey, J., Simeoni, L., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03075.x · Cited by 124
Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., MacLennan, S., & Borea, P. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413772200 · Cited by 124
Geoghegan, J. C., Diedrich, G., Lu, X., Rosenthal, K., Sachsenmeier, K. F., Wu, H., Dall’Acqua, W. F., & Damschroder, M. M. (2016) · mAbs · doi:10.1080/19420862.2016.1143182 · Cited by 123
Integration of Calcium and Cyclic AMP Signaling Pathways by 14-3-3
Chow, C.-W., & Davis, R. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.702-712.2000 · Cited by 122
Zhang, H., Xia, Y., Ye, Q., Yu, F., Zhu, W., Li, P., Wei, Z., Yang, Y., Shi, Y., Thomson, A. W., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3411-17.2018 · Cited by 120
McColl, S. R., St‐Onge, M., Dussault, A., Laflamme, C., Bouchard, L., Boulanger, J., & Pouliot, M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4804fje · Cited by 118
Zhou, J., Riquelme, M. A., Gao, X., Ellies, L. G., Sun, L., & Jiang, J. X. (2014) · Oncogene · doi:10.1038/onc.2014.113 · Cited by 117
CD73-Generated Adenosine: Orchestrating the Tumor-Stroma Interplay to Promote Cancer Growth
Allard, B., Turcotte, M., & Stagg, J. (2012) · BioMed Research International · doi:10.1155/2012/485156 · Cited by 117
Yang, M., Ma, C., Liu, S., Shao, Q., Gao, W., Song, B., Sun, J., Xie, Q., Zhang, Y., Feng, A., et al. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.77 · Cited by 115
Desai, A., Victor-Vega, C., Gadangi, S., Montesinos, M. C., Chu, C. C., & Cronstein, B. N. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007807 · Cited by 115
Kerkelä, E., Laitinen, A., Räbinä, J., Valkonen, S., Takatalo, M. S., Larjo, A., Veijola, J., Lampinen, M., Siljander, P. R. M., Lehenkari, P. P., et al. (2016) · Stem Cells · doi:10.1002/stem.2280 · Cited by 115
Gessi, S., Merighi, S., Varani, K., Cattabriga, E., Benini, A., Mirandola, P., Leung, E., Lennan, S. M., Feo, C. V., Baraldi, S., et al. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20994 · Cited by 114
Sorrentino, C., Miele, L., Porta, A., Pinto, A., & Morello, S. (2015) · Oncotarget · doi:10.18632/oncotarget.4393 · Cited by 113
Disordered Purinergic Signaling Inhibits Pathological Angiogenesis in Cd39/Entpd1-Null Mice
Jackson, S. W., Hoshi, T., Wu, Y., Sun, X., Enjyoji, K., Cszimadia, E., Sundberg, C., & Robson, S. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070190 · Cited by 113
Microdialysis of intercellular adenosine concentration in subcutaneous tissue in humans
Lönnroth, P., Jansson, P., Fredholm, B. B., & Smith, U. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.2.e250 · Cited by 112
Hai, Z., Bo, C., Kang, Y., & Li, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00727 · Cited by 112
CD73 Promotes Resistance to HER2/ErbB2 Antibody Therapy
Turcotte, M., Allard, D., Mittal, D., Barèche, Y., Buisseret, L., José, V., Pommey, S., Delisle, V., Loi, S., Joensuu, H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0707 · Cited by 112
Extracellular adenosine regulates naive T cell development and peripheral maintenance
Cekic, C., Sağ, D., Day, Y., & Linden, J. M. (2013) · The Journal of Experimental Medicine · doi:10.1084/jem.20130249 · Cited by 111
Bhutia, Y. D., Hung, S. W., Patel, B., Lovin, D., & Govindarajan, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2736 · Cited by 111
Skålhegg, B. S. (2000) · Frontiers in bioscience · doi:10.2741/a543 · Cited by 111
cAMP Signaling Compartmentation: Adenylyl Cyclases as Anchors of Dynamic Signaling Complexes
Johnstone, T. B., Agarwal, S. R., Harvey, R. D., & Ostrom, R. S. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.110825 · Cited by 110
Häusler, S. F., del Barrio, I. M., Diessner, J., Stein, R. G., Strohschein, J., Hönig, A., Dietl, J., & Wischhusen, J. (2014) · Europe PMC (PubMed Central) · Cited by 109
The A2B Adenosine Receptor Promotes Th17 Differentiation via Stimulation of Dendritic Cell IL-6
Wilson, J. M., Kurtz, C. C., Black, S. G., Ross, W. G., Alam, M. S., Linden, J. M., & Ernst, P. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100117 · Cited by 109
Firestein, G. S., Bullough, D. A., Erion, M. D., Jimenez, R., Ramirez‐Weinhouse, M. M., Barankiewicz, J., Smith, C. W., Gruber, H. E., & Mullane, K. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.326 · Cited by 107
Expression of A3 Adenosine Receptors in Human Lymphocytes: Up-Regulation in T Cell Activation
Gessi, S., Varani, K., Merighi, S., Cattabriga, E., Avitabile, A., Gavioli, R., Fortini, C., Leung, E., Lennan, S. M., & Borea, P. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.65.3.711 · Cited by 104
Hedrich, C. M., Rauen, T., & Tsokos, G. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299339 · Cited by 103
Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
Young, A., Ngiow, S. F., Madore, J., Reinhardt, J., Landsberg, J., Chitsazan, A., Rautela, J., Bald, T., Barkauskas, D. S., Ahern, E. S., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0393 · Cited by 103
Mediavilla-Varela, M., Luddy, K. A., Noyes, D. R., Khalil, F. K., Neuger, A. M., Soliman, H. H., & Antonia, S. J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25643 · Cited by 102
Liu, Y., Wang, L., Han, R., Beier, U. H., Akimova, T., Bhatti, T. R., Xiao, H., Cole, P. A., Brindle, P. K., & Hancock, W. W. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00919-14 · Cited by 100
A2B adenosine receptor blockade inhibits growth of prostate cancer cells
Wei, Q., Costanzi, S., Balasubramanian, R., Gao, Z., & Jacobson, K. A. (2013) · Purinergic Signalling · doi:10.1007/s11302-012-9350-3 · Cited by 100
Adenosine A3 Receptor Suppresses Prostate Cancer Metastasis by Inhibiting NADPH Oxidase Activity
Jajoo, S., Mukherjea, D., Watabe, K., & Ramkumar, V. (2009) · Neoplasia · doi:10.1593/neo.09744 · Cited by 99
Epigenetic Control of Interferon-Gamma Expression in CD8 T Cells
de Araujo‐Souza, P. S., Hanschke, S. C. H., & Viola, J. P. B. (2015) · Journal of Immunology Research · doi:10.1155/2015/849573 · Cited by 99
Samten, B., Townsend, J. C., Weis, S. E., Bhoumik, A., Klucar, P., Shams, H., & Barnes, P. F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.2056 · Cited by 99
Camici, M., Garcia‐Gil, M., & Tozzi, M. G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030784 · Cited by 99
Sarkar, K., Cai, Z. P., Gupta, R., Parajuli, N., Fox-Talbot, K., Darshan, M. S., Gonzalez, F. J., & Semenza, G. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208314109 · Cited by 97
Expression of the nucleoside‐derived drug transporters hCNT1, hENT1 and hENT2 in gynecologic tumors
Farré, X., Guillén‐Gómez, E., Sánchez, L., Hardisson, D., Plaza, Y., Lloberas, J., Casado, F. J., Palacios, J., & Pastor‐Anglada, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20524 · Cited by 96
Emerging Roles of Human Prostatic Acid Phosphatase
Kong, H. Y., & Byun, J. (2013) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.095 · Cited by 96
Liao, H., Hyman, M. C., Baek, A. E., Fukase, K., & Pinsky, D. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116905 · Cited by 95
Adenosine acts as an inhibitor of lymphoma cell growth
Fishman, P., Bar‐Yehuda, S., Ohana, G., Pathak, S., Wasserman, L., Barer, F., & Multani, A. S. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00130-1 · Cited by 95
A3 Adenosine Receptors Modulate Hypoxia-inducible Factor-1a Expression in Human A375 Melanoma Cells
Merighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., MacLennan, S., Baraldi, P. G., & Borea, P. A. (2005) · Neoplasia · doi:10.1593/neo.05334 · Cited by 94
Mediavilla-Varela, M., Castro, J., Chiappori, A., Noyes, D. R., Hernandez, D. C., Allard, B., Stagg, J., & Antonia, S. J. (2017) · Neoplasia · doi:10.1016/j.neo.2017.02.004 · Cited by 94
The future of EPAC-targeted therapies: agonism versus antagonism
Parnell, E., Palmer, T. M., & Yarwood, S. J. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.003 · Cited by 92
Aandahl, E. M., Moretto, W. J., Haslett, P. A. J., Vang, T., Bryn, T., Taskén, K., & Nixon, D. F. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.802 · Cited by 91
Ohana, G., Bar‐Yehuda, S., Arich, A., Madi, L., Dreznik, Z., Rath‐Wolfson, L., Silberman, D., Slosman, G., & Fishman, P. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601315 · Cited by 91
Differential ectonucleotidase expression in human bladder cancer cell lines
Stella, J., Bavaresco, L., Braganhol, E., Rockenbach, L., Farias, P. F., Wink, M. R., Azambuja, A. A., Barrios, C. H., Morrone, F. B., & Battastini, A. M. O. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2009.01.035 · Cited by 90
Sullivan, G. W., Lee, D. D., Ross, W. G., DiVietro, J. A., Lappas, C. M., Lawrence, M. B., & Linden, J. M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603300 · Cited by 90
Challier, J., Bruniquel, D., Sewell, A. K., & Laugel, B. (2012) · Immunology · doi:10.1111/imm.12053 · Cited by 89
Mechanisms of induction of adenosine receptor genes and its functional significance
Hilaire, C. S., Carroll, S. H., Chen, H., & Ravid, K. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21579 · Cited by 89
Adenosine A2b receptor promotes progression of human oral cancer
Kasama, H., Sakamoto, Y., Kasamatsu, A., Okamoto, A., Koyama, T., Minakawa, Y., Ogawara, K., Yokoe, H., Shiiba, M., Tanzawa, H., et al. (2015) · BMC Cancer · doi:10.1186/s12885-015-1577-2 · Cited by 88
Alam, M. S., Kurtz, C. C., Wilson, J. M., Burnette, B. R., Wiznerowicz, E. B., Ross, W. G., Rieger, J. M., Figler, R. A., Linden, J. M., Crowe, S. E., et al. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.4 · Cited by 88
Ren, H., Sun, L., Li, H., & Ye, Z. (2015) · BioMed Research International · doi:10.1155/2015/160835 · Cited by 88
Distinct Roles of Adenylyl Cyclase VII in Regulating the Immune Responses in Mice
Duan, B., Davis, R., Sadat, E. L., Collins, J. N. R., Sternweis, P. C., Yuan, D., & Jiang, L. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903474 · Cited by 88
Sądej, R., & Składanowski, A. C. (2012) · Acta Biochimica Polonica · doi:10.18388/abp.2012_2105 · Cited by 87
Hilchey, S. P., Kobie, J. J., Cochran, M. R., Secor‐Socha, S., Wang, J.-C. E., Hyrien, O., Burack, R., Mosmann, T. R., Quataert, S. A., & Bernstein, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900475 · Cited by 87
Safety and Tolerability of Adoptive Cell Therapy in Cancer
Wolf, B., Zimmermann, S., Arber, C., Irving, M. B., Trueb, L., & Coukos, G. (2019) · Drug Safety · doi:10.1007/s40264-018-0779-3 · Cited by 87
Self-citationNiemelä, J., Henttinen, T. A., Yegutkin, G. G., Airas, L. M., Kujari, A.-M., Rajala, P., & Jalkanen, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1646 · Cited by 86
Hoskin, D. W., Butler, J. J., Drapeau, D., Haeryfar, S. M. M., & Blay, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10325 · Cited by 86
Ecto‐ATP diphosphohydrolase/CD39 is overexpressed in differentiated human melanomas
Dzhandzhugazyan, K. N., Kirkin, A. F., Straten, P. T., & Zeuthen, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00603-6 · Cited by 86
Spychała, J., & Kitajewski, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.11.001 · Cited by 86
Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma
Forte, G., Sorrentino, R., Montinaro, A., Luciano, A., Adcock, I. M., Maiolino, P., Arra, C., Cicala, C., Pinto, A., & Morello, S. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200744 · Cited by 86
Mora‐García, M. D. L., García‐Rocha, R., Morales-Ramírez, O., Montesinos, J. J., Weiss‐Steider, B., Hernández‐Montes, J., Ávila-Ibarra, L. R., Don‐López, C. A., Velasco-Velázquez, M. A., Gutiérrez-Serrano, V., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1057-8 · Cited by 85
Xu, Y., Wang, Y., Yan, S., Zhou, Y., Yang, Q., Pan, Y., Zeng, X., An, X., Liu, Z., Wang, L., et al. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607066 · Cited by 85
MacKenzie, W. M., Hoskin, D. W., & Blay, J. (1994) · PubMed · Cited by 84
Tokunaga, A., Tsukimoto, M., Harada, H., Moriyama, Y., & Kojima, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112417 · Cited by 84
Merighi, S., Simioni, C., Gessi, S., Varani, K., Mirandola, P., Tabrizi, M. A., Baraldi, P. G., & Borea, P. A. (2009) · Neoplasia · doi:10.1593/neo.09768 · Cited by 83
Mirza, A., Basso, A., Black, S., Malkowski, M. G., Kwee, L., Patcher, J. A., Lachowicz, J. E., Wang, Y., & Liu, S. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.12.2196 · Cited by 82
Coordinate Transactivation of the Interleukin-2 CD28 Response Element by c-Rel and ATF-1/CREB2
Butscher, W. G., Powers, C., Olive, M., Vinson, C., & Gardner, K. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.552 · Cited by 82
Adenosine Receptors in Wound Healing, Fibrosis and Angiogenesis
Feoktistov, I., Biaggioni, I., & Cronstein, B. N. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-89615-9_13 · Cited by 81
Saito, M., Yaguchi, T., Yasuda, Y., Nakano, T., & Nishizaki, T. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.011 · Cited by 81
Carey, K. D., Dillon, T. J., Schmitt, J., Baird, A. M., Holdorf, A. D., Straus, D. B., Shaw, A. S., & Stork, P. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8409-8419.2000 · Cited by 81
Pouliot, M., Fiset, M.-É., Massé, M., Naccache, P. H., & Borgeat, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5279 · Cited by 80
Yasuda, Y., Saito, M., Yamamura, T., Yaguchi, T., & Nishizaki, T. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2273-7 · Cited by 80
Lukashev, D. E., Smith, P. T., Caldwell, C. C., Ohta, A., Apasov, S. G., & Sitkovsky, M. V. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00158-8 · Cited by 80
da Silva, C. G., Jarzyna, R., Specht, A., & Kaczmarek, E. (2006) · Circulation Research · doi:10.1161/01.res.0000215436.92414.1d · Cited by 80
Engineering Chimeric Antigen Receptor T-Cells for Racing in Solid Tumors: Don’t Forget the Fuel
Irving, M. B., de Silly, R. V., Scholten, K. B. J., Dilek, N., & Coukos, G. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00267 · Cited by 80
Self-citationMerighi, S., Benini, A., Mirandola, P., Gessi, S., Varani, K., Leung, E., MacLennan, S., Baraldi, P. G., & Borea, P. A. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031849 · Cited by 79
Delgado, M., & Ganea, D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.1028 · Cited by 78
CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells
Bu, X., Kato, J., Hong, J. A., Merino, M. J., Schrump, D. S., Lund, F. E., & Moss, J. (2017) · Carcinogenesis · doi:10.1093/carcin/bgx137 · Cited by 78
Gourdin, N., Bossennec, M., Rodriguez, C., Viganó, S., Machon, C., Jandus, C., Bauché, D., Faget, J., Durand, I., Chopin, N., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2405 · Cited by 78
Self-citationRole of cAMP in regulating cytotoxic T lymphocyte adhesion and motility
Valitutti, S., Dessing, M., & Lanzavecchia, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230403 · Cited by 76
Sai, K., Yang, D., Yamamoto, H., FUJIKAWA, H., Yamamoto, S., NAGATA, T., Saito, M., YAMAMURA, T., & NISHIZAKI, T. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2005.12.008 · Cited by 76
Ramstad, C., Sundvold, V., Johansen, H. K., & Lea, T. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00097-8 · Cited by 76
Longhi, M. S., Moss, A. C., Bai, A., Wu, Y., Huang, H., Cheifetz, A. S., Quintana, F. J., & Robson, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087956 · Cited by 76
Prostatic acid phosphatase expression in human tissues.
Graddis, T. J., McMahan, C. J., Tamman, J., et al. (2011) · PubMed · Cited by 75
Myeloid cells in the tumor microenvironment: Role of adenosine
Morello, S., Pinto, A., Blandizzi, C., & Antonioli, L. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1108515 · Cited by 75
Himer, L., Csóka, B., Selmeczy, Z., Koscsó, B., Pócza, T., Pacher, P., Németh, Z. H., Deitch, E. A., Vizi, E. S., Cronstein, B. N., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-155192 · Cited by 74
Cai, X., Ni, X., Yi, Y., He, H.-W., Wang, J., Fu, Y., Sun, J., Zhou, J., Cheng, Y., Jin, J., et al. (2016) · Medicine · doi:10.1097/md.0000000000004989 · Cited by 74
cAMP: a multifaceted modulator of immune synapse assembly and T cell activation
Arumugham, V. B., & Baldari, C. T. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ru1116-474r · Cited by 74
PLC gamma 1, a possible mediator of T cell receptor function.
Granja, C., Lin, L. L., Yunis, E. J., Relias, V., & Dasgupta, J. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55290-x · Cited by 73
Wirsdörfer, F., de Leve, S., Cappuccini, F., Eldh, T., Meyer, A. V., Gau, E., Thompson, L. F., Chen, N., Karmouty‐Quintana, H., Fischer, U., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2310 · Cited by 73
D'Almeida, S. M., Kauffenstein, G., Roy, C., Basset, L., Papargyris, L., Henrion, D., Catros, V., Ifrah, N., Descamps, P., Croué, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1178025 · Cited by 72
Thiel, M., & Choukèr, A. (1995) · PubMed · Cited by 72
Extracellular NAD+: a danger signal hindering regulatory T cells
Adriouch, S., Haag, F., Boyer, O., Séman, M., & Koch‐Nolte, F. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.05.011 · Cited by 71
Hedrich, C. M., Rauen, T., Kis‐Tóth, K., Kyttaris, V. C., & Tsokos, G. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.323261 · Cited by 71
Bjørgo, E., Solheim, S., Abrahamsen, H., Baillie, G. S., Brown, K. M., Berge, T., Okkenhaug, K., Houslay, M. D., & Taskén, K. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00696-09 · Cited by 71
Thiel, M., Chambers, J. D., Choukèr, A., Fischer, S., Zourelidis, C., Bardenheuer, H. J., Arfors, K. ‐., & Peter, K. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.5.671 · Cited by 71
PDE8 Regulates Rapid Teff Cell Adhesion and Proliferation Independent of ICER
Vang, A. G., Ben-Sasson, S. Z., Dong, H., Kream, B. E., DeNinno, M. P., Claffey, M. M., Housley, W., Clark, R. B., Epstein, P. M., & Brocke, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012011 · Cited by 70
Bartik, M. M., Brooks, W. H., & Roszman, T. L. (1993) · Cellular Immunology · doi:10.1006/cimm.1993.1122 · Cited by 70
Tissue-specific Regulation of the Ecto-5′-nucleotidase Promoter
Spychała, J., Zimmermann, A. G., & Mitchell, B. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22705 · Cited by 70
Lin, Z., Yin, P., Reierstad, S., O'Halloran, M., Coon, J. S., Pearson, E. K., Mutlu, G. M., & Bulun, S. E. (2009) · Oncogene · doi:10.1038/onc.2009.409 · Cited by 69
Feng, G. L., Nadig, S. N., Bäckdahl, L., Beck, S., Francis, R. S., Șchiopu, A., Whatcott, A., Wood, K. J., & Bushell, A. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002099 · Cited by 69
Savic, V., Stefanović, V., ARDAILLOU, N., et al. (1990) · PubMed · Cited by 68
Su, Y., Huang, X., Raskovalova, T., Zacharia, L. C., Lokshin, A. E., Jackson, E. K., & Gorelik, E. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0494-5 · Cited by 68
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors
Gessi, S., Sacchetto, V., Fogli, E., Merighi, S., Varani, K., Baraldi, P. G., Tabrizi, M. A., Leung, E., MacLennan, S., & Borea, P. A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.009 · Cited by 68
Tak, E., Jung, D., Kim, S., Park, G., Jun, D. Y., Lee, J., Jung, B.-H., Kirchner, V. A., Hwang, S., Song, G., et al. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.11.016 · Cited by 68
The listed authors are on behalf of the Health Economic Evaluation Working Group, C. S. P. I. U. C. (., Sun, X., Shi, J., Guo, L.-W., Huang, H., Yao, N. A., Gong, J., Sun, Y., Liu, G., Mao, A., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4357-y · Cited by 68
Gessi, S., Bencivenni, S., Battistello, E., Vincenzi, F., Colotta, V., Catarzi, D., Varano, F., Merighi, S., Borea, P. A., & Varani, K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00888 · Cited by 67
Aghaei, M., Panjehpour, M., Karami‐Tehrani, F., & Salami, S. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1031-z · Cited by 65
Paccani, S. R., Molin, F. D., Benagiano, M., Ladant, D., D’Elios, M. M., Montecucco, C., & Baldari, C. T. (2008) · Infection and Immunity · doi:10.1128/iai.00200-08 · Cited by 65
Levy, A., Blacher, E., Vaknine, H., Lund, F. E., Stein, R., & Mayo, L. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos121 · Cited by 65
Henttinen, T. A., Jalkanen, S., & Yegutkin, G. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300779200 · Cited by 65
Černý, O., Kamanová, J., Mašín, J., Bibova, I., Škopová, K., & Šebo, P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402941 · Cited by 64
Richter, J. (1992) · Journal of Leukocyte Biology · doi:10.1002/jlb.51.3.270 · Cited by 64
High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
Aliagas, E., Vidal, A., Texidó, L., Ponce, J., Condom, E., & Martín-Satué, M. (2014) · Mediators of Inflammation · doi:10.1155/2014/509027 · Cited by 61
Fernández, P., Pérez‐Aso, M., Smith, G. P., Wilder, T., Trzaska, S., Chiriboga, L. A., Franks, A. G., Robson, S. C., Cronstein, B. N., & Chan, E. S. L. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.08.024 · Cited by 60
Miller, J. S., Cervenka, T., Lund, J., Okazaki, I. J., & Moss, J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.12.7376 · Cited by 59
Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma
Hernanda, P. Y., Pedroza‐González, A., van der Laan, L. J. W., Bröker, M. E. E., Hoogduijn, M. J., IJzermans, J. N. M., Bruno, M. J., Janssen, H. L. A., Peppelenbosch, M. P., & Pan, Q. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt210 · Cited by 59
Zhou, Y., Chu, X., Deng, F., Tong, L., Tong, G., Ye, Y., Liu, J., Tang, J. H., Tang, Y., Xia, Y., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17835 · Cited by 59
Thibaudin, M., Chaix, M., Boidot, R., Végran, F., Dérangère, V., Limagne, E., Berger, H., Ladoire, S., Apétoh, L., & Ghiringhelli, F. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1055444 · Cited by 58
Solomou, E. E., Juang, Y., & Tsokos, G. C. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5665 · Cited by 58
Chimote, A. A., Hajdú, P., Kucher, V., Boiko, N., Kuras, Z., Szilágyi, O., Yun, Y., & Conforti, L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300702 · Cited by 58
Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche
Quarona, V., Ferri, V., Chillemi, A., Bolzoni, M., Mancini, C., Zaccarello, G., Roato, I., Morandi, F., Marimpietri, D., Faccani, G., et al. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12485 · Cited by 58
Anderson, P. O., & González‐Rey, E. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01282-09 · Cited by 57
Borger, P., Kauffman, H. F., Postma, D. S., & Vellenga, E. (1996) · Blood · doi:10.1182/blood.v87.2.691.bloodjournal872691 · Cited by 57
Belfiore, A., Costantino, A., Frasca, F., Pandini, G., Mineo, R., Vigneri, P. G., Maddux, B. A., Goldfine, I. D., & Vigneri, R. (1996) · Molecular Endocrinology · doi:10.1210/me.10.11.1318 · Cited by 56
Najar, H. M., Rühl, S., Bru-Capdeville, A. C., & Peters, J. H. (1990) · Journal of Leukocyte Biology · doi:10.1002/jlb.47.5.429 · Cited by 55
Adenosine receptors and modulation of natural killer cell activity by purine nucleosides.
Priebe, T. S., Platsoucas, C. D., & Nelson, J. A. (1990) · PubMed · Cited by 54
Visser, S. S., Theron, A. J., Ramafi, G. J., et al. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00414-7 · Cited by 54
Palmer, D., Jimmo, S. L., Raymond, D. R., Wilson, L. S., Carter, R. L., & Maurice, D. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606936200 · Cited by 54
The CREB/CRTC2 pathway modulates autoimmune disease by promoting Th17 differentiation
Hernandez, J. B., Chang, C., LeBlanc, M., Grimm, D., Le Lay, J., Kaestner, K. H., Zheng, Y., & Montminy, M. (2015) · Nature Communications · doi:10.1038/ncomms8216 · Cited by 53
Bandini, S., Curcio, C., Macagno, M., Quaglino, E., Arigoni, M., Lanzardo, S., Hysi, A., Barutello, G., Consolino, L., Longo, D. L., et al. (2013) · OncoImmunology · doi:10.4161/onci.26137 · Cited by 53
Adenosine contribution to normal renal physiology and chronic kidney disease
Oyarzun, C. E., Garrido, W., Alarcón, S., Yáñez, A. J., Sobrevía, L., Quezada, C., & Martín, R. S. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.004 · Cited by 53
Rodriguez, G., Ross, J. A., Nagy, Z. S., & Kirken, R. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.408765 · Cited by 52
Wakai, A., Wang, J. H., Winter, D. C., Street, J., O’Sullivan, R., & Redmond, H. P. (2001) · Shock · doi:10.1097/00024382-200115040-00008 · Cited by 52
Sakowicz‐Burkiewicz, M., Kocbuch, K., Grdeń, M., et al. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02380.x · Cited by 51
Brown, K. M., Lee, L. C. Y., Findlay, J. E., Day, J. P., & Baillie, G. S. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.033 · Cited by 51
Prostatic acid phosphatase expression in human tissues
Graddis, T. J., McMahan, C. J., Tamman, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/diag-10-b29 · Cited by 51
Wang, X., Ni, L., Chang, D., Li, J., Jiang, Y., Kim, B., Wang, A., Liu, X., Zhong, B., Yang, X. O., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.010 · Cited by 51
Extracellular Adenine Nucleotides Inhibit the Activation of Human CD4+ T Lymphocytes
Duhant, X., Schandené, L., Bruyns, C., Gonzalez, N. S., Goldman, M., Boeynaems, J., & Communi, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.15 · Cited by 50
Grader‐Beck, T., van Puijenbroek, A. A. F. L., Nadler, L. M., & Boussiotis, V. A. (2003) · Blood · doi:10.1182/blood-2002-06-1665 · Cited by 50
Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages
Haschemi, A., Wagner, O. F., Marculescu, R., Wegiel, B., Robson, S. C., Gagliani, N., Gallo, D. J., Chen, J., Bach, F. H., & Otterbein, L. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5921 · Cited by 50
Varani, K., Maniero, S., Vincenzi, F., Targa, M., Stefanelli, A., Maniscalco, P., Martini, F., Tognon, M. G., & Borea, P. A. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0980oc · Cited by 50
Zalavary, S., Stendahl, O. I., & Bengtsson, T. (1994) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(94)90176-7 · Cited by 49
Williams, B. A., Manzer, A., Blay, J., & Hoskin, D. W. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6077 · Cited by 49
Kanda, N., & Watanabe, S. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00688-8 · Cited by 48
Prostatic acid phosphatase, a neglected ectonucleotidase
Zimmermann, H. (2009) · Purinergic Signalling · doi:10.1007/s11302-009-9157-z · Cited by 47
Hofer, S., Ivarsson, L., Stoitzner, P., Auffinger, M., Romani, N., Heufler, C., & Rainer, C. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12369.x · Cited by 47
Giansanti, P., Stokes, M. P., Silva, J. C., Scholten, A., & Heck, A. J. R. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o113.028456 · Cited by 47
Wong, R., & Schlichter, L. C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1008-14.2014 · Cited by 47
Chung, H., Jung, J., Cho, S., Hong, K.-A., Kim, H., Shin, D., Kim, H., Kim, H. O., Shin, D. H., Lee, H. W., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0245 · Cited by 46
Sorrentino, C., Miele, L., Porta, A., Pinto, A., & Morello, S. (2016) · Oncotarget · doi:10.18632/oncotarget.11729 · Cited by 45
Srinivas, S. P., Satpathy, M., Gallagher, P. J., Larivière, E., & Driessche, W. V. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.06.027 · Cited by 44
Multi-Inhibitory Effects of A2A Adenosine Receptor Signaling on Neutrophil Adhesion Under Flow
Yago, T., Tsukamoto, H., Liu, Z., Wang, Y., Thompson, L. F., & McEver, R. P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500775 · Cited by 43
Wong, R., & Schlichter, L. C. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.11.711 · Cited by 43
Shaikh, G., Zhang, J., Pérez‐Aso, M., Mediero, A., & Cronstein, B. N. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13615 · Cited by 43
Cazaux, C. A., Sterin‐Borda, L., Gorelik, G. J., & Cremaschi, G. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00366-h · Cited by 42
Adenosine Suppresses α4β7 Integrin-Mediated Adhesion of T Lymphocytes to Colon Adenocarcinoma Cells
MacKenzie, W. M., Hoskin, D. W., & Blay, J. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5514 · Cited by 42
CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma.
Hayes, G. M., Cairns, B., Levashova, Z. B., Chinn, L., Perez, M., Theunissen, J.-W. F., Liao-Chan, S., Bermudez, A., Flory, M. R., Schweighofer, K. J., et al. (2015) · PubMed Central · Cited by 41
Pagnotta, S. M., Laudanna, C., Pancione, M., Sabatino, L., Votino, C., Remo, A., Cerulo, L., Zoppoli, P., Manfrin, E., Colantuoni, V., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072638 · Cited by 40
Koizume, S., & Miyagi, Y. (2015) · Cancers · doi:10.3390/cancers8010002 · Cited by 40
Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells
Bazhin, A. V., Kahnert, S., Kimpfler, S., Schadendorf, D., & Umansky, V. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.10.032 · Cited by 38
Oberprieler, N. G., Lemeer, S., Kalland, M. E., Torgersen, K. M., Heck, A. J. R., & Taskén, K. (2010) · Blood · doi:10.1182/blood-2010-01-266650 · Cited by 38
Role of ATP as a Key Signaling Molecule Mediating Radiation-Induced Biological Effects
Kojima, S., Ohshima, Y., Nakatsukasa, H., & Tsukimoto, M. (2017) · Dose-Response · doi:10.1177/1559325817690638 · Cited by 38
Nevedomskaya, E., Perryman, R., Solanki, S., Syed, N., Mayboroda, O. A., & Keun, H. C. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00793 · Cited by 37
Jafari, S. M., Joshaghani, H., Panjehpour, M., & Aghaei, M. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0359-z · Cited by 34
Walker, G., Langheinrich, A. C., Dennhauser, E., Bohle, R. M., Dreyer, T., Kreuzer, J., Tillmanns, H., Braun-Dullaeus, R. C., & Haberbosch, W. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.11.2673 · Cited by 32
A3Adenosine Receptor-Mediated p53-Dependent Apoptosis in Lu-65 Human Lung Cancer Cells
Otsuki, T., Kanno, T., Fujita, Y., Tabata, C., Fukuoka, K., Nakano, T., Gotoh, A., & Nishizaki, T. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000339058 · Cited by 30
Medina-Pulido, L., Molina‐Arcas, M., Justicia, C., Soriano, E., Burgaya, F., Planas, A. M., & Pastor‐Anglada, M. (2013) · Biochemical Journal · doi:10.1042/bj20130231 · Cited by 30
Kim, H., Kang, J. W., Lee, S., Choi, W. J., Jeong, L. S., Yang, Y. D., Hong, J. T., & Yoon, D. Y. (2010) · PubMed · Cited by 30
Costales, M. G., Alam, M. S., Cavanaugh, C., & Williams, K. M. (2017) · Nitric Oxide · doi:10.1016/j.niox.2017.11.001 · Cited by 30
Adenosine arrests breast cancer cell motility by A3 receptor stimulation
Ledderose, C., Hefti, M. M., Chen, Y., Bao, Y., Seier, T., Li, L., Woehrle, T., Zhang, J., & JUNGER, W. G. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9531-6 · Cited by 28
Kanno, T., Nakano, T., Fujita, Y., Gotoh, A., & Nishizaki, T. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000341447 · Cited by 27
Adenosine A1 receptor modifies P53 expression and apoptosis in breast cancer cell line Mcf-7
Dastjerdi, M. N., Valiani, A., Mardani, M., & Zamani, M. M. (2016) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2016_046 · Cited by 27
Kuras, Z., Kucher, V., Gordon, S. M., Neumeier, L., Chimote, A. A., Filipovich, A. H., & Conforti, L. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00263.2011 · Cited by 26
Adenosine inhibits superoxide production in rat peritoneal macrophages via elevation of cAMP level
Si, Q.-S., Nakamura, Y., & Kataoka, K. (1997) · Immunopharmacology · doi:10.1016/s0162-3109(96)00158-0 · Cited by 26
Zhang, J., Ravichandran, K. S., & Garrison, J. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128827 · Cited by 25
Anderson, R., Visser, S. S., Ramafi, G. J., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703344 · Cited by 25
Sakowicz‐Burkiewicz, M., Kitowska, A., Grdeń, M., et al. (2013) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2013.02.007 · Cited by 24
Bodor, J., Bodorova, J., Bare, C. V., Hodge, D. L., Young, H. A., & Gress, R. E. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200201)32:1<203::aid-immu203>3.0.co;2-c · Cited by 24
Kobayashi, M., Shimomura, A., Hagiwara, M., & Kawakami, K. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.4.877 · Cited by 24
Takayama, H., & Sitkovsky, M. V. (1989) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600780104 · Cited by 22
Adenosine A2Aand A2Breceptor activation of erythropoietin production
Fisher, J. W., & Brookins, J. W. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0083.2001 · Cited by 19
p73 engages A2B receptor signalling to prime cancer cells to chemotherapy-induced death
Long, J. S., Schoonen, P. M., Graczyk, D., O’Prey, J., & Ryan, K. M. (2015) · Oncogene · doi:10.1038/onc.2014.436 · Cited by 19
Cited by
Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy
Mager, L. F., Burkhard, R., Pett, N., Cooke, N. C. A., Brown, K., Ramay, H., Paik, S., Stagg, J., Groves, R. A., Gallo, M., et al. (2020) · Science · doi:10.1126/science.abc3421 · Cited by 1,407
Turning cold tumors into hot tumors by improving T-cell infiltration
Liu, Y.-T., & Sun, Z.-J. (2021) · Theranostics · doi:10.7150/thno.58390 · Cited by 827
The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses
Labani-Motlagh, A., Ashja-Mahdavi, M., & Loskog, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00940 · Cited by 751
The adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 586
Next generation of immune checkpoint inhibitors and beyond
Marin-Acevedo, J. A., Kimbrough, E. O., & Lou, Y. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01056-8 · Cited by 548
Metadata
- Authors
- Vigano, S., Alatzoglou, D., Irving, M., Ménétrier-Caux, C., Caux, C., Romero, P., & Coukos, G.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2019-06-06
- Volume
- 10
- Pages
- 925-925
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2947747173
- Cited by
- 420
- References
- 411
- FWCI
- 33.35
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.